| Literature DB >> 16854049 |
Pascal Furet1, Guido Bold, Thomas Meyer, Johannes Roesel, Vito Guagnano.
Abstract
FLT3 kinase inhibitors are currently under investigation as a new treatment for acute myeloid leukemia. We report here a molecular concept invoking interactions between an aromatic ring and the side chains of Phe691 and Cys828, two residues of the ATP pocket, to obtain potent and specific inhibitors of this kinase. The hypothesis has been validated by the successful design of a new inhibitor prototype showing promising antiproliferative activity in cellular assays.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16854049 DOI: 10.1021/jm060368s
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446